— First order is first step to improve food security at world’s largest pig market —
DUBLIN, IRELAND–(Newsfile Corp. – 30 November 2022) – Tonisity International Limited (“Tonicity”), the Ireland-based animal health and nutrition company, is pleased to announce that it has received its first purchase order for Tonisity Px.® (pixel), an innovative isotonic protein solution for improving gut health and piglet performance from a joint venture in China.
Following the registration of Px by the Ministry of Agriculture and Rural Affairs of China, the General Administration of Customs of the People’s Republic of China (GACC) approved the import of Px into China in August 2022, and Tonisity is pleased to announce it. plans to ship the first full container of Tonisity Px to China in December 2022. Pig farmers in China will now be able to benefit from this unique solution that has helped producers improve the health and performance of pigs around the world since 2016.
About Tonisity Px
Tonisity Px is a patented isotonic protein drink that directly feeds enterocytes in the small intestine of certain animals, including piglets, accelerating and increasing the absorption of all nutrients into the animal’s body. Resulting in weight gain (360g weaning weight, ~3.1kg final), reduced mortality (mean 20%), reduced lag (up to 60% reduction), and reduced need for medication in these animals. To do. High return on investment for growers. Improved gut health will finish more, heavier pigs. Tonisity Px is patented in many countries around the world and is currently available in Europe, Asia, North America, South America and Australia. Tonisity Px is now manufactured in Ireland.
Joint venture in China
In July 2020, Tonisity entered into a joint venture agreement with a minority partner in China as the controlling partner to market Tonisity’s swine and companion products in China, including Hong Kong, and Taiwan. Tonisity contributed technology and intellectual property to the joint venture, and joint venture partners contributed funding, local senior management, sales, marketing and logistics teams. China is the world’s largest pork consumer, and he accounts for more than 54 million tons of the world’s pork consumption of 112 million tons. Tonisity companion animal products will launch in Hong Kong in January 2021, while Tonisity Px will be soft-launching alongside select pig producers in China.
OEM production in China
Tonisity and its joint venture partner have contracted a Chinese original equipment manufacturer to locally process Tonisity’s swine products for the Chinese market. With Px registration, Tonisity plans to start processing his Px in China in the first quarter of 2023, and is gearing up to produce all other hog and companion products in China in the near future. increase.
Tonisity CEO Arie Halpern commented: A nutritional feeding approach reduces pre-weaning mortality by first improving gut health in pigs and setting them to improve lifetime performance across key performance indicators. The shipment will be the first step for Tonisity to offer a new nutritional product to support farmers in the world’s largest hog market, and we are working diligently to obtain regulatory approval for the rest of our products.”
For more information on Tonisity, visit
Tonisity is an Ireland-based animal health science and nutrition company that currently focuses its patented technology on two specific markets. (2) new companion animal nutrition products; Tonisity focuses on creating positive physiological changes by addressing gut health issues in young animals. With new companion animal products, Tonisity is poised to be the pioneer and market leader in targeted nutritional approaches for pets, a rapidly growing market worldwide. For more information on Tonisity’s isotonic business, please visit www.tonisity.com. For more information on Tonisity’s companion animal business, please visit www.doggyrade.com.
On behalf of the Board of Directors
This press release contains forward-looking statements and information that are based on management’s beliefs and reflect Tonisity’s current expectations. As used in this press release, “estimate”, “predict”, “believe”, “expect”, “intend”, “expect”, “plan”, “predict”, “possible” The words “may” or “should” and negative forms of these words or variations thereof or equivalent terms are intended to identify forward-looking statements and information. .
The forward-looking statements and information in this press release reflect Tonisity’s business plans, including expansion in China and Taiwan, processing of products in China, and development of new product lines in both the pig and companion animal product lines. contains information about .
Such statements and information reflect Tonisity’s current views. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements, or other Future events may differ materially from any future results, performance or achievements expressed or implied by us. such forward-looking statements. Such factors include, among others, the risks of: Tonisity’s ability to raise capital to sustain its growth and business objectives; the geographic markets that Tonisity has negotiated and are part of its expansion plans; the ability to enter into binding agreements with other parties; the ability of Tonisity to operate; changes in laws and regulations that may adversely affect Tonisity’s business, growth or performance in the Chinese market; attracting and retaining Tonisity’s customers and consumers; and the impact of the COVID-19 pandemic.
There are several important factors that could cause Tonisity’s actual results to differ materially from those indicated or implied by the forward-looking statements and information. Such factors include, among others: risks associated with Tonisity’s corporate strategy, including the failure of past and future acquisitions to meet expectations; disruptions or changes in the credit or securities markets; results of operational activities; unexpected costs and expenses, commodity price fluctuations and general market and industry conditions; Protection of Tonisity Intellectual Property. Disruption at any of Tonisity’s facilities, including as a result of the current COVID-19 pandemic. Impact of public health crises, including the current COVID-19 pandemic. Tonisity Supply Chain Management. availability of raw material suppliers; limited or interrupted supply of key raw materials; Availability of key ingredients in Tonisity’s products. Failure to expand production capacity. effects of product innovation; failure to retain existing customers and/or acquire new customers; potential volatility in stock prices; There is no guarantee of an active market for stocks. dividends; global financial conditions; impact of product labeling requirements; prices of raw materials; consumer trends; publication of inaccurate or unfavorable studies or reports; Management and Conflicts of Interest.
Tonisity warns that the list of key factors above isn’t exhaustive. Readers should carefully consider the aforementioned factors and other uncertainties and potential events when making decisions based on Tonisity’s forward-looking statements and information. Tonisity does not expect such forward-looking statements or information to differ materially from actual results or events due to the important factors referred to in the preceding paragraph. However, this list of factors is not exhaustive, is subject to change, and there is no guarantee that such assumptions will reflect the actual results of such items or factors.
The forward-looking information contained in this press release represents Tonisity’s expectations as of the date of this press release and is therefore subject to change after that date. Readers should not place undue weight on forward-looking information or rely on this information as of any other date. Tonisity reserves the right to choose, but makes no commitment to update this information at any particular time, except as required by applicable law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/146221.